442 related articles for article (PubMed ID: 10549736)
1. A personal experience with pancreatic and duodenal neuroendocrine tumors.
Jordan PH
J Am Coll Surg; 1999 Nov; 189(5):470-82. PubMed ID: 10549736
[TBL] [Abstract][Full Text] [Related]
2. Determinants of surgical resection for pancreatic neuroendocrine tumors.
Doi R
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):610-7. PubMed ID: 25773163
[TBL] [Abstract][Full Text] [Related]
3. Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1.
MacFarlane MP; Fraker DL; Alexander HR; Norton JA; Lubensky I; Jensen RT
Surgery; 1995 Dec; 118(6):973-9; discussion 979-80. PubMed ID: 7491542
[TBL] [Abstract][Full Text] [Related]
4. Surgery for gastrinoma and insulinoma in multiple endocrine neoplasia type 1.
Norton JA; Fang TD; Jensen RT
J Natl Compr Canc Netw; 2006 Feb; 4(2):148-53. PubMed ID: 16451771
[TBL] [Abstract][Full Text] [Related]
5. Biliary tree gastrinomas in multiple endocrine neoplasia type 1 syndrome.
Tonelli F; Giudici F; Nesi G; Batignani G; Brandi ML
World J Gastroenterol; 2013 Dec; 19(45):8312-20. PubMed ID: 24363522
[TBL] [Abstract][Full Text] [Related]
6. Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients.
Imamura M; Komoto I; Ota S; Hiratsuka T; Kosugi S; Doi R; Awane M; Inoue N
World J Gastroenterol; 2011 Mar; 17(10):1343-53. PubMed ID: 21455335
[TBL] [Abstract][Full Text] [Related]
7. Operation for insulinomas in multiple endocrine neoplasia type 1: When pancreatoduodenectomy is appropriate.
Tonelli F; Giudici F; Nesi G; Batignani G; Brandi ML
Surgery; 2017 Mar; 161(3):727-734. PubMed ID: 27863775
[TBL] [Abstract][Full Text] [Related]
8. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative methods to stage and localize pancreatic and duodenal tumors.
Norton JA
Ann Oncol; 1999; 10 Suppl 4():182-4. PubMed ID: 10436817
[TBL] [Abstract][Full Text] [Related]
10. Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type I.
Pipeleers-Marichal M; Donow C; Heitz PU; Klöppel G
World J Surg; 1993; 17(4):481-8. PubMed ID: 8103250
[TBL] [Abstract][Full Text] [Related]
11. Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both.
Thompson NW
J Intern Med; 1998 Jun; 243(6):495-500. PubMed ID: 9681848
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis.
Poultsides GA; Huang LC; Chen Y; Visser BC; Pai RK; Jeffrey RB; Park WG; Chen AM; Kunz PL; Fisher GA; Norton JA
Ann Surg Oncol; 2012 Jul; 19(7):2295-303. PubMed ID: 22396008
[TBL] [Abstract][Full Text] [Related]
13. Surgical pathology of gastrinoma. Site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy.
Donow C; Pipeleers-Marichal M; Schröder S; Stamm B; Heitz PU; Klöppel G
Cancer; 1991 Sep; 68(6):1329-34. PubMed ID: 1678681
[TBL] [Abstract][Full Text] [Related]
14. [Surgical treatment of gastric, enteric, and pancreatic endocrine tumors Part 1. Treatment of primary endocrine tumors].
Kianmanesh R; O'toole D; Sauvanet A; Ruszniewski P; Belghiti J
J Chir (Paris); 2005; 142(3):132-49. PubMed ID: 16142076
[TBL] [Abstract][Full Text] [Related]
15. Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors?
Fernández-Cruz L; Blanco L; Cosa R; Rendón H
World J Surg; 2008 May; 32(5):904-17. PubMed ID: 18264824
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics of duodenal microgastrinomas.
Imamura M; Kanda M; Takahashi K; Shimada Y; Miyahara T; Wagata T; Hashimoto M; Tobe T; Soga J
World J Surg; 1992; 16(4):703-9; discussion 709-10. PubMed ID: 1357832
[TBL] [Abstract][Full Text] [Related]
17. Selective surgical management of correctable hypergastrinemia.
Delcore R; Hermreck AS; Friesen SR
Surgery; 1989 Dec; 106(6):1094-100; discussion 1100-2. PubMed ID: 2573956
[TBL] [Abstract][Full Text] [Related]
18. Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I.
Bordi C; Falchetti A; Azzoni C; D'Adda T; Canavese G; Guariglia A; Santini D; Tomassetti P; Brandi ML
Am J Surg Pathol; 1997 Sep; 21(9):1075-82. PubMed ID: 9298884
[TBL] [Abstract][Full Text] [Related]
19. Surgical experience with functioning pancreatic neuroendocrine tumors.
Matthews BD; Smith TI; Kercher KW; Holder WD; Heniford BT
Am Surg; 2002 Aug; 68(8):660-5; discussion 665-6. PubMed ID: 12206598
[TBL] [Abstract][Full Text] [Related]
20. Long-term results of a selective surgical approach to management of Zollinger-Ellison syndrome in patients with MEN-1.
Mortellaro VE; Hochwald SN; McGuigan JE; Copeland EM; Vogel SB; Grobmyer SR
Am Surg; 2009 Aug; 75(8):730-3. PubMed ID: 19725300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
